中国破裂颅内动脉瘤临床管理指南(2024版)解读  

Interpretation of Chinese guideline for the clinical management of patients with ruptured intracranial aneurysms(2024)

作　　者：江裕华[1] 李润亭 林发 陈玉 陈晓霖[1] Jiang Yuhua;Li Runting;Lin Fa;Chen Yu;Chen Xiaolin(Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China)

机构地区：[1]首都医科大学附属北京天坛医院神经外科,北京100070

出　　处：《中华医学杂志》2024年第21期1907-1910,共4页National Medical Journal of China

基　　金：国家重点研发计划(2021YFC2501100)

摘　　要：动脉瘤性蛛网膜下腔出血(aSAH)是一种高致死率的神经外科急症,即使患者接受了最佳的医疗护理,仍有可能出现长期残疾,严重影响患者生活质量,给社会和家庭增加了沉重的医疗负担。为提供全面的临床管理意见,中华医学会神经外科学分会、中国卒中学会脑血管外科分会、国家神经系统疾病医学中心与国家神经系统疾病临床研究中心联合制订《中国破裂颅内动脉瘤临床管理指南(2024版)》,将证据来源分为中国人群和其他人群,并采用模块化形式,对aSAH的流行病学、临床影像诊断、预后评价、治疗策略及选择、麻醉管理、围手术期护理和特殊人群aSAH管理建议等问题提供推荐意见、相关意见概述及未来研究方向,为医师及相关专业人员提供了实用的临床指导建议。Aneurysmal subarachnoid hemorrhage(aSAH)is a life-threatening neurological emergency with high mortality,and even patients receiving optimal medical care may develop long-term disability,which seriously affects their quality of life and increases the heavy medical burden on society and families.To provide comprehensive clinical management advice,the Society of Neurosurgery of the Chinese Medical Association,the Society of the Chinese Stroke Association of the National Medical Center for Neurological Diseases,and the National Clinical Research Center for Neurological Diseases jointly formulate"Chinese Guidelines for the Clinical Management of Patients With Ruptured Intracranial Aneurysms in 2024".The evidence sources are divided into the Chinese population and other populations,using a modular format to provide recommendations,summaries of relevant opinions,and future research directions on epidemiology,clinical imaging diagnosis,prognosis evaluation,treatment strategies and choices,anesthesia management,perioperative care,and recommendations for the management of aSAH in special populations.It provides practical clinical guidance and recommendations for doctors and related professionals.

关 键 词：蛛网膜下腔出血 动脉瘤 指南 临床管理 

分 类 号：R743[医药卫生—神经病学与精神病学]